Bizelesin

DB12352InvestigationalSmall molecule

Bizelesin has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Chemical structure of Bizelesin
Formula / weight
C43H36Cl2N8O5 · 815.71 g/mol (avg)
Code names
U-77779

Resolves to

Compound
UNIIL0O9OBI87ECAS129655-21-6ChEMBLCHEMBL284642PubChem60794
Structure
InChIKeyFONKWHRXTPJODV-DNQXCXABSA-NSMILESCC1=CNC2=C(O)C=C3N(C[C@@H](CCl)C3=C12)C(=O)C1=CC2=CC(NC(=O)NC3=CC=C4NC(=CC4=C3)C(=O)N3C[C@@H](CCl)C4=C5C(C)=CNC5=C(O)C=C34)=CC=C2N1

What you can answer from here — as of February 21, 2021

39Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Bizelesin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In